A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy

Ophthalmic Genetics

Volumn 23, Issue 4, 2002, Pages 209-223

  Schmidt, Silke ^a   Klaver, Caroline C W ^b   Saunders, Ann M ^a   Postel, Eric A ^a   De La Paz, Monica A ^a   Agarwal, Anita ^c   Small, Kent W ^d   Udar, Nitin ^d   Ong, John M ^e   Chalukya, Meenal V ^e   Nesburn, Anthony ^e   Kenney, M Cristina ^e   Domurath, Ruth M ^a   Hogan, Molly ^f   Mah, Tammy S ^g   Conley, Yvette P ^h   Ferrell, Robert E ^h   Weeks, Daniel E ^h   De Jong, Paulus T V M ^b,i   Van Duijn, Cornelia M ^b   Haines, Jonathan L ^f   Pericak Vance, Margaret A ^a   Gorin, Michael B ^g,h   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d JULES STEIN EYE INSTITUTE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Age related macular degeneration; APOE; Candidate geness; Epidemiology

Indexed keywords

AGE; AGED; ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUROPE; FEMALE; GENDER; GENE; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RETINA MACULOPATHY; RISK; STATISTICAL ANALYSIS; UNITED STATES;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0037000982     PISSN: 13816810     EISSN: None     Source Type: Journal    
DOI: 10.1076/opge.23.4.209.13883     Document Type: Article

References (52)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
2. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, De Jong PT. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
3. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 1993;115:786-791.
4. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001;119:198-207.
5. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, De Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697-704.
6. Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study [published erratum appears in Genet Epidemiol. 1994;11(6):571]. Genet Epidemiol. 1994;11:51-67.
7. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol. 1995;120:757-766.
8. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: A twin study. Ophthalmology. 2002;109:730-736.
9. Klaver CC, Wolfs RC, Assink JJ, Van Duijn CM, Hofman A, De Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1646-1651.
10. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123:199-206.
11. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye. 1994;8:564-568.
12. Hyman LG, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol. 1983;118:213-227.
13. Allikmets R and the International ABCR Screening Consortium. Further evidence for an association of ABCR alleles with age-related macular degeneration. Am J Hum Genet. 2000;67:487-491.
14. Klaver CCW, Van Duijn CM, Hofman A, et al. Does apolipoprotein E polymorphism play a role in age-related macular degeneration? [Abstract] Invest Ophthalmol Vis Sci. 1996;37:S413.
15. Klaver CC, Kliffen M, Van Duijn CM, Hofman A, Cruts M, Grobbee DE, Van Broeckhoven C, De Jong PT. Genetic association of apolipoprotein E with age-related macular degeneration [published erratum appears in Am J Hum Genet. 1998 Oct;63(4):1252]. Am J Hum Genet. 1998;63:200-206.
16. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane G. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 1998;125:353-359.
17. Schmidt S, Saunders AM, De La Paz MA, Postel EA, Heinis RM, Agarwal A, Scott WK, Gilbert JR, McDowell JG, Bazyk A, et al. Association of the apolipoprotein E gene with age-related macular degeneration: Possible effect modification by family history, age, and gender. Mol Vis. 2000;6:287-293.
18. Simonelli F, Margaglione M, Testa F, Cappucci G, Manitto MP, Brancato R, Rinaldi E. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res. 2001;33:325-328.
19. Magnusson KP, Sigurdsson H, Smarason S, et al. Genetic association of apolipoprotein E with severe exudative age-related macular degeneration (AMD). [Abstract] Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 5-10, 2002, Ft. Lauderdale, FL.
20. Baird PN, Guida E, Cain M, et al. Association studies of the apolipoprotein E (ApoE) gene and age-related macular degeneration (AMD). [Abstract] Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 5-10, 2002, Ft. Lauderdale, FL.
21. Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC. Drusen as risk factors in age-related macular disease. Am J Ophthalmol. 1990;109:38-43.
22. Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA. 1986;83:1125-1129.
23. Poirier J, Baccichet A, Dea D, Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 1993;55:81-90.
24. Schneeberger SA, Iwahashi CK, Hjelmeland LM, Davis PA, Morse LS. Apolipoprotein E in the subretinal fluid of rhegmatogenous and exudative retinal detachments. Retina. 1997;17:38-43.
25. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
26. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr. PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
27. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica. 2000;214:289-291.
28. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, De Jong PT, Klaver CC, Klein BE, Klein R. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
29. De La Paz MA, Guy VK, Abou-donia SM, Heinis R, Bracken B, Vance JM, Gilbert JR, Gass JDM, Haines JL, Pericak-Vance MA. Stargardt disease gene (ABCR) mutations in age-related macular degeneration. Ophthalmology. 1999;106:1531-1536.
30. Weeks DE, Conley YP, Mah TS, Paul TO, Morse L, Ngo-Chang J, Dailey JP, Ferrell RE, Gorin MB. A full genome scan for age-related maculopathy. Hum Mol Genet. 2000;9:1329-1349.
31. Vance JM, Haines JL, Pericak-Vance MA, editors. Approaches to gene mapping in complex human diseases. New York: Wiley-Liss, 1998;8:201-211. Chapter 8; The collection of biological samples for DNA analysis.
32. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
33. Van Duijn CM, De Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
34. Scuteri A, Bos AJ, Zonderman AB, Brant LJ, Lakatta EG, Fleg JL. Is the apoE4 allele an independent predictor of coronary events? Am J Med. 2001;110:28-32.
35. Davignon J, Cohn JS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin Chim Acta. 1999;286:115-143.
36. Chew ST, Newman MF, White WD, Conlon P, Saunders A, Strittmatter WJ, Landolfo K, Grocott HP, Stafford-Smith M. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatine concentrations in cardiac surgical patients. Anesthesiology. 2000;93:325-331.
37. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506-516.
38. Risch N, Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases: DNA pooling. Genome Res. 1998;8:1273-1288.
39. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA. 1998;95:11389-11393.
40. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, Van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J Am Med Assoc. 1997;278:1349-1356.
41. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847-856.
42. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. J Natl Cancer Inst. 2000;92:115I-1158.
43. Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: Implications for the process of drusen formation. Am J Ophthalmol. 2001;131:767-781.
44. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
45. 3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol. 2000;84:1415-1419.
46. Dithmar S, Curcio CA, Le NA, Brown S, Grossniklaus HE. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci. 2000;41:2035-2042.
47. Ong JM, Zorapapel NC, Rich KA, Wagstaff RE, Lambert RW, Rosenberg SE, Moghaddas F, Pirouzmanesh A, Aoki AM, Kenney MC. Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice. Invest Ophthalmol Vis Sci. 2001;42:1891-1900.
48. Cai J, Nelson KC, Wu M, Sternberg Jr. P, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
49. Colton CA, Czapiga M, Snell-Callanan J, Chernyshev ON, Vitek MP. Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. Biochim Biophys Acta. 2001;1535:134-144.
50. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal. 2001;3:203-213.
51. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Lendon C, et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet. 1998;7:1511-1516.
52. Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, García MA, Lendon CL, Han SW, Morris JC, Vázquez J, et al. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum Mol Genet. 1998;7:1887-1892.